XERIS BIOPHARMA HOLDINGS, INC.
XERIS BIOPHARMA HOLDINGS, INC. is a registered legal entity registered in United States under 5933929, and its current status with Delaware Division of Corporations is active. The company was incorporated on 5 August 2022 and lists its registered address as United States. 5 shareholders are on record for XERIS BIOPHARMA HOLDINGS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for XERIS BIOPHARMA HOLDINGS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 16.4% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 5.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 7 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 16.4% | Delaware Division of Corporations | |
| iShares Trust-iShares Russell 2000 ETF | 5.7% | Delaware Division of Corporations | |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.6% | Delaware Division of Corporations | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.3% | Delaware Division of Corporations | |
| iShares Trust-iShares Russell 2000 Growth ETF | 2% | Delaware Division of Corporations |
Officers
5
The Ceo & Director of XERIS BIOPHARMA HOLDINGS, INC. currently on record is John P. Shannon; five officers are currently on record for XERIS BIOPHARMA HOLDINGS, INC., filed with Delaware Division of Corporations.
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at XERIS BIOPHARMA HOLDINGS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
XERIS BIOPHARMA HOLDINGS, INC. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 3 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
XERIS BIOPHARMA HOLDINGS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns XERIS BIOPHARMA HOLDINGS, INC.?
Five shareholders are currently on record for XERIS BIOPHARMA HOLDINGS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 16.4% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 5.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is XERIS BIOPHARMA HOLDINGS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for XERIS BIOPHARMA HOLDINGS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does XERIS BIOPHARMA HOLDINGS, INC. have on record?
5 shareholders are shown on record for XERIS BIOPHARMA HOLDINGS, INC.. The register reports 7 in total; only the top 5 by holding are shown here.
What is XERIS BIOPHARMA HOLDINGS, INC.'s company registration number?
XERIS BIOPHARMA HOLDINGS, INC.'s registration number is 5933929, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is XERIS BIOPHARMA HOLDINGS, INC. still an active company?
XERIS BIOPHARMA HOLDINGS, INC.'s status on Delaware Division of Corporations is listed as active.
When was XERIS BIOPHARMA HOLDINGS, INC. incorporated?
XERIS BIOPHARMA HOLDINGS, INC. was incorporated on 5 August 2022, according to Delaware Division of Corporations.
What is XERIS BIOPHARMA HOLDINGS, INC.'s registered address?
The registered address on file for XERIS BIOPHARMA HOLDINGS, INC. is United States.
Who are the officers/directors of XERIS BIOPHARMA HOLDINGS, INC.?
The Ceo & Director of XERIS BIOPHARMA HOLDINGS, INC. currently on record is John P. Shannon; five officers are currently on record for XERIS BIOPHARMA HOLDINGS, INC., filed with Delaware Division of Corporations. Management authority at XERIS BIOPHARMA HOLDINGS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does XERIS BIOPHARMA HOLDINGS, INC. have a parent company or subsidiaries?
XERIS BIOPHARMA HOLDINGS, INC. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 2 jurisdictions. Those 3 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 3 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to XERIS BIOPHARMA HOLDINGS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to XERIS BIOPHARMA HOLDINGS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access XERIS BIOPHARMA HOLDINGS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like XERIS BIOPHARMA HOLDINGS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.